Circulation Genomic and Precision Medicine· 2026Q1
Cardiovascular Genetic Counseling Is Associated With Improved Patient-Reported Outcomes Across Clinical Indications and Settings
- 2citations
- Q1SCImago
- 2026year
Short summary
Cardiovascular genetic counseling (CVGC) significantly increases patient empowerment (+5.94 points on GCOS-24) and reduces worry (-0.40 points on CWS) and cardiac fear (-0.034 points on CAQ fear subscale) in adults attending outpatient appointments, according to a study of 890 patients.
AI-generated from the title and abstract; the full text is not read.
Key points
- CVGC increased patient empowerment by 5.94 points on the GCOS-24 scale (p<0.001).
- CVGC decreased patient worry by 0.40 points on the CWS scale (p=0.002).
- CVGC reduced cardiac fear by 0.034 points on the CAQ fear subscale (p=0.033).
- The patient-counselor alliance was positively associated with increased empowerment (p<0.001).
AI-generated from the title and abstract; the full text is not read.
Abstract
Background: Contemporary guidelines recommend genetic counseling for potentially inherited cardiomyopathies, channelopathies, aortopathies, and dyslipidemias, but few, small, studies characterize cardiovascular genetic counseling (CVGC) outcomes impeding efforts to improve CVGC service delivery. We aimed to 1) quantify psychosocial CVGC outcomes, 2) identify clinical, demographic, and service delivery characteristics associated with extent of benefit from CVGC, and 3) determine how outcomes are associated with patient-reported quality of the genetic counselor (GC):patient alliance. Methods: 890 adults attending a first outpatient CVGC appointment at eight United States and Canadian medical centers completed questionnaires assessing empowerment (Genetic Counseling Outcome Scale [GCOS-24]), worry (modified Cancer Worry Scale [CWS]), cardiac anxiety (Cardiac Anxiety Questionnaire [CAQ]), and GC:patient alliance (Working Alliance Inventory-patient [WAI-SR]) prior to and up to 4 weeks post-CVGC, but before results of genetic tests ordered were returned to decouple CVGC and genetic test result impact. Results: Following CVGC, empowerment increased (GCOS-24 change: +5.94±11.6, p<0.001), worry decreased (CWS change: -0.40±3.55, p=0.002), and cardiac fear decreased (CAQ fear subscale change: -0.034±0.46, p=0.033) with no change in whole-scale CAQ (0.013±0.34, p=0.29). In linear regression, worry decreased most in patients with less formal education (p=0.0021), with an arrhythmia indication (p=0.013), and who were at-risk family members (p=0.016) while strength of the GC:patient alliance had no impact. In contrast, the GC:patient alliance was strongly positively associated with change in empowerment (p<0.001). Conclusions: This observational, multicenter, multiprovider study provides foundational evidence that CVGC is associated with increased empowerment and decreased worry in adults attending outpatient CVGC and suggests opportunities for optimizing CVGC services.
The authors' abstract, as published at the source. Circulation Genomic and Precision Medicine, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Cardiology and Cardiovascular Medicine
Cardiology and Cardiovascular MedicineMedicine